Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Jan;27(1):15–20. doi: 10.1128/iai.27.1.15-20.1980

Effect of rifampin on the immune response in mice.

A Bellahsène, A Forsgren
PMCID: PMC550714  PMID: 6987166

Abstract

In an investigation of the effect of rifampin on the immune response in mice, the cellular immunity was evaluated with the split-heart allograft technique. The survival time of the heart in animals treated with rifampin at a dose of 20 mg/kg per day from the day of the transplantation until the graft was rejected was longer (33.7 days, P less than 0.001) than that of animals not treated with antibiotics (14.5 days). When rifampin was given at a dose of 5 mg/kg per day for the same period, the mean survival time of allografts was 19.5 days. The number of demonstrable plaques of hemolysis and the humoral antibodies to sheep erythrocytes were also reduced by a human therapeutic dose (20 mg/kg per day). However, the suppression of the humoral immune response was probably of more limited biological significane, suggesting a differential sensitivity to rifampin. In contrast to rifampin, benzylpenicillin had no noteworthy inhibiting effect on the cellular or humoral immune response.

Full text

PDF
15

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassi L., Di Berardino L., Arioli V., Silvestri L. G., Lignière E. L. Conditions for immunosuppression by rifampicin. J Infect Dis. 1973 Dec;128(6):736–744. doi: 10.1093/infdis/128.6.736. [DOI] [PubMed] [Google Scholar]
  2. Blomgren H., Andersson B. Characteristics of the immunocompetent cells in the mouse thymus: cell population changes during cortisone-induced atrophy and subsequent regeneration. Cell Immunol. 1970 Nov;1(5):545–560. doi: 10.1016/0008-8749(70)90041-9. [DOI] [PubMed] [Google Scholar]
  3. Dajani B. M., Kasik J. E., Thompson J. S. Effect of rifampin on the immune response in guinea pigs. Antimicrob Agents Chemother. 1973 Apr;3(4):451–455. doi: 10.1128/aac.3.4.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fauci A. S., Pratt K. R. Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3676–3679. doi: 10.1073/pnas.73.10.3676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Forsgren A., Schmeling D. Effect of antibiotics of chemotaxis of human leukocytes. Antimicrob Agents Chemother. 1977 Apr;11(4):580–584. doi: 10.1128/aac.11.4.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Forsgren A., Svedjelund A., Wigzell H. Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol. 1976 Mar;6(3):207–213. doi: 10.1002/eji.1830060312. [DOI] [PubMed] [Google Scholar]
  7. Grassi G. G., Pozzi E. Effect of rifampicin on delayed-hypersensitivity reactions. J Infect Dis. 1972 Nov;126(5):542–544. doi: 10.1093/infdis/126.5.542. [DOI] [PubMed] [Google Scholar]
  8. Hartmann G., Honikel K. O., Knüsel F., Nüesch J. The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta. 1967;145(3):843–844. doi: 10.1016/0005-2787(67)90147-5. [DOI] [PubMed] [Google Scholar]
  9. Jerne N. K., Nordin A. A. Plaque Formation in Agar by Single Antibody-Producing Cells. Science. 1963 Apr 26;140(3565):405–405. doi: 10.1126/science.140.3565.405. [DOI] [PubMed] [Google Scholar]
  10. Judd K. P., Trentin J. J. Cardiac transplantation in mice. I. Factors influencing the take and survival of heterotopic grafts. Transplantation. 1971 Mar;11(3):298–302. [PubMed] [Google Scholar]
  11. Leete E., Chedekel M. R. Tritium in deuterated compounds. Nature. 1972 Mar 24;236(5343):166–167. doi: 10.1038/236166c0. [DOI] [PubMed] [Google Scholar]
  12. Ljungström I., Huldt G. Effect of experimental trichinosis on unrelated humoral and cell mediated immunity. Acta Pathol Microbiol Scand C. 1977 Apr;85(2):131–141. doi: 10.1111/j.1699-0463.1977.tb03622.x. [DOI] [PubMed] [Google Scholar]
  13. Mandell G. L. Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest. 1973 Jul;52(7):1673–1679. doi: 10.1172/JCI107348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nilsson B. S. Rifampicin: an immunosuppressant? Lancet. 1971 Aug 14;2(7720):374–374. doi: 10.1016/s0140-6736(71)90087-0. [DOI] [PubMed] [Google Scholar]
  15. Păunescu E. In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin. Nature. 1970 Dec 19;228(5277):1188–1190. doi: 10.1038/2281188a0. [DOI] [PubMed] [Google Scholar]
  16. Serrou B., Solassol C., Karcenty L., Joyeux H., Pujol H. Action immunodépressive de la rifampicine. Nouv Presse Med. 1972 May 6;1(19):1295–1295. [PubMed] [Google Scholar]
  17. Velichi N., Radu G. Studiul eşantioanelor în practica dispensarială. Ftiziologia. 1971 Jan-Feb;20(1):49–54. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES